NCT04111822View on ClinicalTrials.gov

Pilot Study on the Use of Hydrocortisone, Vitamin c and Tiamine in Patient With Sepsis and Septic Shock

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2018

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2020

Conditions
SepsisSeptic Shock
Interventions
DRUG

red blood cells transfusion, tranexamic acid (TXA) and fibrinogen concentrate

Phase III, randomized, multicenter, open-label and parallel group pilot study, which aims to study mortality at 28 days of admission in patients with septic shock treated with usual management and patients treated with ascorbic acid, thiamine and hydrocortisone added to usual driving

DRUG

on crystalloid fluid and Tranexamic acid

Resuscitation with crystalloids, Performing culture battery, antibiotic therapy

Trial Locations (1)

17007

Hospital Dr Josep Trueta, Girona

All Listed Sponsors
lead

Cristina Martinez

OTHER

NCT04111822 - Pilot Study on the Use of Hydrocortisone, Vitamin c and Tiamine in Patient With Sepsis and Septic Shock | Biotech Hunter | Biotech Hunter